A meta-analysis of outcomes of conventional IVF in women with polycystic ovary syndrome

Human Reproduction Update

Volumn 12, Issue 1, 2006, Pages 13-21

  Heijnen, E M E W ^a,b   Eijkemans, M J C ^b   Hughes, E G ^b   Laven, J S E ^c   Macklon, N S ^b   Fauser, B C J M ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

^b ERASMUS MEDICAL CENTER   (Netherlands)

^c MCMASTER UNIVERSITY   (Canada)

Author keywords

IVF outcome; Meta analysis; PCOS

Indexed keywords

CLOMIFENE CITRATE; FOLLITROPIN; GONADORELIN AGONIST; HUMAN MENOPAUSAL GONADOTROPIN;

ANOVULATION; CHILDBIRTH; CLINICAL PROTOCOL; CLINICAL TRIAL; CONCEPTION; CONFIDENCE INTERVAL; EMBRYO TRANSFER; FEMALE; FEMALE INFERTILITY; FERTILIZATION IN VITRO; HUMAN; META ANALYSIS; OOCYTE DONATION; OUTCOMES RESEARCH; OVARY DISEASE; OVARY POLYCYSTIC DISEASE; OVULATION INDUCTION; PREGNANCY; PREGNANCY RATE; PRIORITY JOURNAL; REVIEW; SYSTEMATIC REVIEW; TREATMENT FAILURE;

FEMALE; FERTILIZATION IN VITRO; GONADOTROPINS; HUMANS; INFERTILITY, FEMALE; OOCYTES; OVARIAN HYPERSTIMULATION SYNDROME; OVULATION INDUCTION; POLYCYSTIC OVARY SYNDROME; PREGNANCY; PREGNANCY RATE; PREGNANCY, MULTIPLE; TREATMENT OUTCOME;

EID: 29544446253     PISSN: 13554786     EISSN: 14602369     Source Type: Journal    
DOI: 10.1093/humupd/dmi036     Document Type: Review

References (39)

1. Aboulghar MA and Mansour RT (2003) Ovarian hyperstimulation syndrome: classifications and critical analysis of preventive measures. Hum Reprod Update 9,275-289.
2. Balen AH (1993) Hypersecretion of luteinizing hormone and the polycystic ovary syndrome. Hum Reprod 8(Suppl. 2),123-128.
3. Balen AH, Tan SL and Jacobs HS (1993) Hypersecretion of luteinising hormone: A significant cause of infertility and miscarriage. Br J Obstet Gynaecol 100,1082-1089.
4. Beck J, Boothroyd C, Proctor M, Farquhar C and Hughes E (2005) Oral anti-oestrogens and medical adjuncts for subfertility associated with anovulation. Cochrane Database Syst Rev, CDO02249.
5. Bodis J, Torok A and Tinneberg HR (1997) LH/FSH ratio as a predictor of ovarian hyperstimulation syndrome. Hum Reprod 12,869-870.
6. Delvigne A and Rozenberg S (2002) Epidemiology and prevention of ovarian hyperstimulation syndrome (OHSS): A review. Hum Reprod Update 8,559-577.
7. Delvigne A and Rozenberg S (2003) Review of clinical course and treatment of ovarian hyperstimulation syndrome (OHSS). Hum Reprod Update 9,77-96.
8. Delvigne A, Demoulin A, Smitz J, Donnez J, Koninckx P, Dhont M, Englert Y, Delbeke L, Darcis L, Gordts S et al. (1993a) The ovarian hyperstimulation syndrome in in-vitro fertilization: A Belgian multicentric study. I. Clinical and biological features. Hum Reprod 8,1353-1360.
9. Delvigne A, Dubois M, Battheu B, Bassil S, Meuleman C, De Sutter P, Rodesch C, Janssens P, Remacle P, Gordts S et al. (1993b) The ovarian byperstimulation syndrome in in-vitro fertilization: A Belgian multicentric study. II. Multiple discriminant analysis for risk prediction. Hum Reprod 8,1361-1366.
10. Doldi N, Marsiglio E, Destefani A, Gessi A, Merati G and Ferrari A (1999) Elevated serum progesterone on the day of HCG administration in IVF is associated with a higher pregnancy rate in polycystic ovary syndrome. Hum Reprod 14,601-605.
11. Dor J, Shulman A, Levran D, Ben Rafael Z, Rudak E and Mashiach S (1990) The treatment of patients with polycystic ovarian syndrome by in-vitro fertilization and embryo transfer: A comparison of results with those of patients with tubal infertility. Hum Reprod 5,816-818.
12. Eijkemans MJ, Imani B, Mulders AG, Habbema JD and Fauser BC (2003) High singleton live birth rate following classical ovulation induction in normogonadotrophic anovulatory infertility (WHO 2). Hum Reprod 18,2357-2362.
13. Farquhar C, Vandekerckhove P and Lilford R (2001) Laparoscopic "drilling" by diathermy or laser for ovulation induction in anovulatory polycystic ovary syndrome. Cochrane Database Syst Rev CD001122.
14. Fauser BCJM, Devroey P and Macklon NS (2005) Multiple birth resulting from ovarian stimulation for subfertility treatment. Lancet 365,1807-1816.
15. Hardy K, Robinson FM, Paraschos T, Wicks R, Franks S and Winston RM (1995) Normal development and metabolic activity of preimplantation embryos in vitro from patients with polycystic ovaries. Hum Reprod 10,2125-2135.
16. Hardy RJ, Thompson SG (1998) Detecting and describing heterogeneity in meta-analysis. Stat Med, 17(8),841-856.
17. Homburg R, Berkowitz D, Levy T, Feldberg D, Ashkenazi J and Ben Rafael Z (1993a) In vitro fertilization and embryo transfer for the treatment of infertility associated with polycystic ovary syndrome. Fertil Steril 60,858-863.
18. Homburg R, Levy T, Berkovitz: D, Farchi J, Feldberg D, Ashkenazi I and Ben Rafael Z (1993b) Gonadotropin-releasing hormone agonist reduces the miscarriage rate for pregnancies achieved in women with polycystic ovarian syndrome. Fertil Steril 59,527-531.
19. Hull MG, Glazener CM, Kelly NJ, Conway DI, Foster PA, Hinton RA, Coulson C, Lambert PA, Watt EM and Desai KM (1985) Population study of causes, treatment, and outcome of infertility. Br Med J (Clin Res Ed) 291,1693-1697.
20. Imani B, Eijkemans MJ, te Velde ER, Habbema JD and Fauser BC (1998) Predictors of patients remaining anovulatory during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 83,2361-2365.
21. Imani B, Eijkemans MJ, te Velde ER, Habbema JD and Fauser BC (1999) Predictors of chances to conceive in ovulatory patients during clomiphene citrate induction of ovulation in normogonadotropic oligoamenorrheic infertility. J Clin Endocrinol Metab 84,1617-1622.
22. Kamat BR, Brown LF, Manseau EJ, Senger DR and Dvorak HF (1995) Expression of vascular permeability factor/vascular endothelial growth factor by human granulosa and theca lutein cells. Role in corpus luteum development. Am J Pathol 146,157-165.
23. Kodama H, Fukuda J, Karube H, Matsui T, Shimizu Y and Tanaka T (1995) High incidence of embryo transfer cancellations in patients with polycystic ovarian syndrome. Hum Reprod 10, 1962-1967.
24. Laven JS and Fauser BC (2004) Inhibins and adult ovarian function. Mol Cell Endocrinol 225,37-44.
25. Lord JM, Flight IH and Norman RJ (2003) Insulin-sensitising drugs (metformin, troglitazone, rosiglitazone, pioglitazone, D-chiro-inositol) for polycystic ovary syndrome. Cochrane Database Syst Rev CD003053.
26. Ludwig M, Finas DF, al Hasani S, Diedrich K and Ortmann O (1999) Oocyte quality and treatment outcome in intracytoplasmic sperm injection cycles of polycystic ovarian syndrome patients. Hum Reprod 14,354-358.
27. MacDougall MJ, Tan SL and Jacobs HS (1992) In-vitro fertilization and the ovarian hyperstimulation syndrome. Hum Reprod 7,597-600.
28. Mitwally MF and Casper RF (2001) Use of an aromatase inhibitor for induction of ovulation in patients with an inadequate response to clomiphene citrate. Fertil Steril 75,305-309.
29. Mulders AG, Laven JS, Imani B, Eijkemans MJ and Fauser BC (2003) IVF outcome in anovulatory infertility (WHO group 2) - including polycystic ovary syndrome - following previous unsuccessful ovulation induction. Reprod Biomed Online 7,50-58.
30. Nardo LG, Rai R, Backos M, El Gaddal S and Regan L (2002) High serum luteinizing hormone and testosterone concentrations do not predict pregnancy outcome in women with recurrent miscarriage. Fertil Steril 77,348-352.
31. Nugent D, Vandekerckhove P, Hughes E, Arnot M and Lilford R (2000) Gonadotrophin therapy for ovulation induction in subfertility associated with polycystic ovary syndrome. Cochrane Database Syst Rev CD000410.
32. Rowe PJ, Comhaire FH, Hargreave TB, Mellows H (2000) Female partner. In Rowe PJ, Comhaire FH, Hargreave TB, Mellows H (eds) WHO Manual for the Standardized Investigation and Diagnosis of the Infertile Couple. Press Syndicate of the University of Cambridge, Cambridge, UK, pp. 40-67.
33. Sengoku K, Tamate K, Takuma N, Yoshida T, Goishi K and Ishikawa M (1997) The chromosomal normality of unfertilized oocytes from patients with polycystic ovarian syndrome. Hum Reprod 12,474-477.
34. Tan SL and Child TJ (2002) In-vitro maturation of oocytes from unstimulated polycystic ovaries. Reprod Biomed Online 4,18-23.
35. The ESHRE Capri Workshop Group (1995) Anovulatory infertility. Hum Reprod 10,1549-1553.
36. The Rotterdam ESHRE/ASRM-sponsored PCOS consensus workshop Group (2004) Revised 2003 consensus on diagnostic criteria and long-term health risks related to polycystic ovary syndrome. Fertil Steril 81,19-25.
37. Urman B, Fluker MR, Yuen BH, Fleige-Zahradka BG, Zouves CG and Moon YS (1992) The outcome of in vitro fertilization and embryo transfer in women with polycystic ovary syndrome failing to conceive after ovulation induction with exogenous gonadotropins. Fertil Steril 57,1269-1273.
38. Urman B, Tiras B and Yakin K (2004) Assisted reproduction in the treatment of polycystic ovarian syndrome. Reprod Biomed Online 8,419-430.
39. Van Santbrink EJ and Fauser BC (2003) Is there a future for ovulation induction in the current era of assisted reproduction? Hum Reprod 18,2499-2502.